Insider Insights: Unveiling Takeaways from AACR 2024
Experts from across the oncology field highlight their biggest takeaways and the hottest topics from the 2024 AACR Annual Meeting.
Stay updated with breaking news from Karan Maxwell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Experts from across the oncology field highlight their biggest takeaways and the hottest topics from the 2024 AACR Annual Meeting.
The TP53 gene provides instructions for making a protein called tumor protein p53 (or p53). Now, a recent study demonstrates men who have mutations in this gene have a high risk of developing aggressive prostate cancer. Their findings suggest men undergoing cancer-risk genetic testing should be checked for mutations in this gene as well.
Men who have mutations in a gene called TP53 have a high risk of developing aggressive prostate cancer, a multicenter research team in the United States has found.
Men who have mutations in a gene called TP53 have a high risk of developing aggressive prostate cancer, a multicenter research team in the United
Men who inherit mutations in a gene called TP53 have a high risk of developing aggressive prostate cancer, a multicenter research team in the United States has found.